目录
更新日期:2024年10月13日
姓 名 汤颖 性 别
民 族 汉族 导师层次 博士导师
技术职称 主任医师 导师类型 学术&专业型
最后学历 博士研究生毕业 最后学位 医学博士学位
行政职务 科室主任 Email ty.102@163.com
工作单位 南方医科大学第三附属医院 邮政编码 510630
个人简介
一、教育经历
1994/09—1999/07,南昌大学(江西医学院)
2002/09—2005/06,中山大学附属第三医院,内科学,医学硕士
2009/09—2012/06,中山大学附属孙逸仙纪念医院,内科学,医学博士

二、研究学习经历

2010/11-2013/05 香港中文大学威尔斯亲王医院李嘉诚医学科学研究所,Research Assistant
2016/01-2016/03 Monash Medical Centre,Australia 访问学者
 
三、承担或参与的科研项目
 
1、Annexin A13改善线粒体功能障碍:急性肾损伤干预的新靶标,国家自然科学基金面上项目,编号:82470711,2025.01-2028.12,课题负责人。
2、缺氧环境中外泌体miR-20a-5p通过CCND1/Hexokinase-2保护急性肾损伤小管上皮细胞线粒体的机制研究,国家自然科学基金面上项目,编号:82070709, 2021.01-2024.12,课题负责人。
3、Smad3/mTOR/PGC-1a 介导线粒体片段化在CRP 抑制急性肾损伤小管上皮细胞增殖的机制研究,国家自然科学青年科学基金项目,编号:81500512, 2016/01-2018/12,课题负责人。
4、缺氧肾小管上皮细胞外泌体miRNA- 20a-5p靶向CCND1促进急性肾损伤修复的机制研究。广东省自然科学基金—面上项目,编号:2019A15150 12197,2019/10-2022/10,课题负责人。
5、沙库巴曲缬沙坦在CKD3b-5期非透析合并轻中度高血压患者中的疗效及安全性的多中心随机对照研究,诺.创高血压科研创新基金,编号:2021-CCA-HTN-62,2021.10-2021.10,课题负责人。
6、CKD3-5 期血尿酸水平及无症状高尿酸血症对其长期预后的影响。中国肾脏病大数据协作网,2022年,课题负责人。
7、缺氧肾小管上皮细胞分泌的外泌体对于急性肾损伤小管上皮细胞增殖修复的影响及机制研究,中山大学重大项目和前沿新兴交叉学科培育资助计划项目,编号:17ykjc19,2017/04-2018/12,课题负责人。
8、慢性肾脏病(CKD 1-3期)患者血管钙化预测模型的建立和验证的前瞻性多中心研究,逸仙临床研究培育项目,2019/01-2022/12 ,课题负责人。
9、Smad3-p21/p27-CDK2 信号通路在CRP介导急性肾损伤的机制研究,中华医学会临床科研专项资金,编号:14050490586,2014/09-2016/09,课题负责人。
10、Smad3-p27-CDK2 信号通路在CRP延缓急性肾损伤修复过程中的作用,广东省中医药局科研课题,编号:20151166,2015/10-2017/10,课题负责人。
11、Smad7在CRP抑制肾小管上皮细胞增殖修复中的作用,广东省自然科学基金, 编号:S2012010009175,2012/10-2014/10,课题负责人。
12、TGF-β1体外诱导的调节性T细胞治疗狼疮肾炎的作用及其机制研究,国家自然科学青年科学基金项目,编号:81400739,2015/01-2017/12,主要参与者(第三)
 

 

研究领域

1.急性肾损伤防治与修复机制;

2.慢性肾脏病早期预警诊断与综合防治;

3.肾小球疾病与肾小管间质性疾病精准化治疗;

4.肾脏康复与肾替代治疗

 

个人成果
一、第一或通讯作者
1、Li X, Yuan F, Xiong Y, Tang Y, Li Z, Ai J, Miao J, Ye W, Zhou S, Wu Q, Wang X, Xu D, Li J, Huang J, Chen Q, Shen W, Liu Y, Hou FF, Zhou L. FAM3A plays a key role in protecting against tubular cell pyroptosis and acute kidney injury. Redox Biol. 2024 Aug;74:103225.(IF 10.7)
2、Luo Y, Song Q, Li J, Fu S, Yu W, Shao X, Li J, Huang Y, Chen J, Tang Y. Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrol. 2024 Feb 23;25(1):63. (IF 2.2)
3、Chen C, Liu L, Liu S, Ju M, Yu W, Song Q, Li M, Tang Y, Wang C. 24-h central pressure is a valuable predictor for left ventricular hypertrophy in non-dialysis patients with chronic kidney disease. Hypertens Res. 2024 Jun;47(6):1697-1706. (IF 4.3)
4、Wu Q, Chen Q, Xu D, Wang X, Ye H, Li X, Xiong Y, Li J, Zhou S, Miao J, Shen W, Liu Y, Niu H, Tang Y, Zhou L. C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-catenin-inhibited fatty acid oxidation. J Cell Mol Med. 2024 Feb;28(3):e18075. (IF 4.3)
5、Junzhe Chen , Ying Tang (co 1st author), Yu Zhong , Biao Wei , Xiao-Ru Huang , Patrick Ming-Kuen Tang , Anping Xu , Hui-Yao Lan. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.Mol Ther. 2022 Jul 5;S1525-0016(22)00420-8. (IF 12.910)
6、Kunyu Shen, Jinhua Miao, Qiongdan Gao, Xian Ling, Ye Liang, Qin Zhou, Qirong Song, Yuxin Luo, Qinyu Wu, Weiwei Shen,Xiaonan Wang, Xiaolong Li, Youhua Liu, Shan Zhou, Ying Tang, Lili Zhou. Annexin A2 plays a key role in protecting against cisplatin-induced AKI through β-catenin/TFEB pathway. Cell Death Discovery. 2022, 8(1): 430.(IF 7.109)
7、Liping Zhou , Yanqin Li , Qi GaoYuxin Lin,Licong Su, Ruixuan Chen,Yue Cao  Ruqi Xu.Fan Luo,Peiyan Gao,Xiaodong Zhang,Pingping Li,Sheng Nie.Ying Tang *, Xin Xu .*and on behalf of the EACH Study Investigators. Loop Diuretics Are Associated with Increased Risk of Hospital-Acquired Acute Kidney Injury in Adult Patients: A Retrospective Study. J Clin Med.2022 Jun 24;11(13):3665.(IF 4.964) 
8、Wenjuan Yu , Honghui Zeng(co 1st author) , Junzhe Chen , Sha Fu, Qiuyan Huang , Yanchun Xu, Anping Xu, Hui-Yao Lan, Ying Tang. miR-20a-5p is enriched in hypoxia-derived tubular exosomes and protects against acute tubular injury.Clin Sci (Lond). 2020 Aug 28;134(16):2223-2234.(IF 6.876)
9、Chen J, Zeng H, Ouyang X, Zhu M, Huang Q, Yu W, Ling L, Lan HY, Xu A,Ying Tang.The incidence, risk factors, and long-term outcomes of acute kidney injury in hospitalized diabetic ketoacidosis patients.BMC Nephrol 2020 Feb:48(IF 2.585)
10、Xu Z, Chen J, Yu W, Li X, Lin B, Lai D, Xu A,Ying Tang. New COL4A5 mutation in IgA nephropathy.Postgrad Med J. 2020(IF 4.973)
11、Sha Fu, Junzhe Chen, Bo Liu, Peifen Liang, Yuchun Zeng, Min Feng, Zhenjian Xu, Guiqiong Zheng, Suqiong Yang, Anping Xu, Ying Tang.Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients.BMC Nephrology(2020)(IF 2.585)
12、Jin H Li , Ying Tang (co 1st author), Jun Lv, Xiao H Wang,Hui Yang,Patrick MK Tang,Xiao R Huang,Zhi J He,Zi J Zhou, Qiu Y Huang, Jörg Klug, Andreas Meinhardt, Günter Fingerle-Rowson, An P Xu, Zhi H Zheng,Hui Y Lan . Macrophage Migration Inhibitory Factor Promotes Renal Injury Induced by Ischemic Reperfusion. J Cell Mol Med. 2019 Jun;23(6):3867-3877 (IF 5.295)
13、Bo Liu, Qiyun Ou,Ying Tang(co 1st author), Sha Fu,Peifen Liang,Yunfang Yu,Zhenjian Xu,Yongjian Chen,Anping Xu. Corticosteroids combined with doublet or single-agent immunosuppressive therapy for active proliferative lupus nephritis. Clin Rheumatol. 2019 May 12. ( IF 3.65)
14、Ying Tang, Peifen Liang, Junzhe Chen, ShaFu, Bo Liu, Min Feng, Baojuan Lin,BenLee,Anping Xu*, Hui Y Lan*. The baseline levels and risk factors for High-sensitive C-reactive protein in Chinese healthy population . Immun Ageing. 2018 Sep 8;15:21. (IF 9.701)
15、Li J, Ying Tang (co 1st author), Tang PMK, Lv J, Huang XR, Carlsson-Skwirut C, Da Costa L, Aspesi A, Fröhlich S, Szczęśniak P, Lacher P, Klug J, Meinhardt A, Fingerle-Rowson G, Gong R, Zheng Z, Xu A, LanHY. Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice. Mol Ther. 2018 Oct 3;26(10):2523-2532(IF 12.910)
16、PeifenLiang, Ying Tang (co 1st author),Liu Lin, Haowen Zhong, HuiYang,Yuchun Zeng, Jun Lv, Xiaomei Li, Yanying Lu, Anping Xu. Low level of circulating basophil counts in biopsy-proven active lupus nephritis. Clinical Rheumatology. 2018 Feb;37(2):459-465.( IF 3.65)
17、Ying Tang, Fung E, Xu A, Lan HY.C-reactive protein and ageing. Clinical and Experimental Pharmacology and Physiology. 2017 ;44Suppl 1:9-14.(IF 2.963)
18、Ying Tang, SHIU-KWONG MAK,AN P XU1 and HUI-YAO LAN. Role of C-reactive protein in the pathogenesis of acute kidney injury. Nephrology 23, Suppl. 4 (2018) 50–52 (IF 2.358)
19、Ying Tang, Junzhe Chen, Kai Huang, Dan Luo, Peifen Liang, Min Feng, Wenxin Chai, Erik Fung, Hui Yao Lan* and Anping Xu*.The incidence, risk factors and in-hospital mortality of acute kidney injury in patients after abdominal aortic aneurysm repair surgery. BMC Nephrology (2017) 18:184. (IF 2.585)
20、Junzhe Chen, Ying Tang(co 1st author),Mingsheng Zhu, Jun Lv, Sha Fu, Huizhen He, YuChun Zeng, Cunjie Lin and Anping Xu*.The Association of echocardiographic parameters with mortality in hospitalized patients with lupus nephritis. Nephrology 22 (2017) 872–884.( IF 2.358)
21、Sha Fu, Ying Tang(co 1st author), Xiao R. Huang, Min Feng, An P. Xu*and HuiY.Lan*. Smad7 protects against acute kidney injury by rescuing tubular epithelial cells from the G1 cell cycle arrest.Clinical Science (2017) 131 1955–1969. (IF 6.876)
22、Weiyan Lai, Ying Tang(co 1st author), Xiao R. Huang, Patrick Ming-Kuen Tang, AnpingXu, Alexander J. Szalai,Tan-qi Lou and Hui Y. Lan*. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclinE. Kidney International (2016).(IF 18.998)
23、Chen J, Ying Tang(co 1st author), Zhu M, Xu A. Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis.Clin Rheumatol. 2016 Oct;35(10):2437-48. (IF 3.65)
24、Tang Y, Huang XR, Lv J, Chung AC, Zhang Y, Chen JZ, Szalai AJ, Xu A, Lan HY. C-reactive protein promotes acute kidney injury by impairing G1/S-dependent tubular epithelium cell regeneration. Clinical Science (Lond). 2014 May;126(9):645-59. (IF 6.876)
25、Sha Fu, Zhenjian Xu, Baojuan Lin, Junzhe Chen, Qiuyan Huang, Yanchun Xu,Anping Xu, Yangxin Chen and Ying Tang. Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis.Frontiers in Medicine(. 2021 Jun 21;8:657067.)(IF 5.058)
26、Zhenjian Xu, Ying Tang(co 1st author), Qiuyan Huang, Sha Fu, Xiaomei Li, Baojuan Lin, Anping Xu and Junzhe Chen. Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19.BMC Nephrol. 2021 Feb 5;22(1):52. (IF 2.585)
27、黄楷,曾玉纯,杨荟,陈钦昌,陈俊哲,梁佩芬,付莎,黄秋燕,汤颖(通讯)。前臂自体动静脉瘘重度狭窄病变的腔内治疗体会。中国血管外科杂志2017年第9卷第3期:192-194。
28、张慧,谭惠丰,汤颖(通讯),戴兵,CAO Zhi-peng。糖尿病合并草酸性肾病致急性肾损伤1例报告。中国实用内科杂志2018年06月
29、余文娟,葛胜南,陈俊哲,曾红惠,徐安平,汤颖(通讯)。慢性肾脏病患者晨尿白蛋白肌酐比值与24小时尿蛋白定量关系的研究。岭南急诊医学杂志,2020年4月,25(02):163-165+169.
30、张慧,杜珍芳,汤颖(通讯)。IgA肾病合并膜性肾病一例.中华肾脏病杂志,2020年3月 (03):240-241.
 
二、非第一或通讯作者
1、Chen C, Zhu Y, Liu L, Ke J, Yu W, Song Q, Li M, Tang Y, Wang C. Associations of 24-Hour Central Systolic Blood Pressure With Multiorgan Damage in Nondialysis Patients With Chronic Kidney Disease. J Am Heart Assoc. 2024 Aug 20;13(16):e034469. 
2、Luo S, Zheng X, Bao W, Nie S, Ding Y, Yue T, Zhou Y, Hu Y, Li H, Yang Q, Wan Q, Liu B, Xu H, Li G, Xu G, Chen C, Liu H, Shi Y, Zha Y, Kong Y, Su G, Tang Y, Gong M, Ji L, Hou FF, Weng J. Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes. Signal Transduct Target Ther. 2024 Jun 6;9(1):154. 
3、Gao Y, Shang Z, Nie S, Feng S, Wang B, Li Z, Wu M, Wen Y, Xu H, Weng J, Chen C, Liu H, Yang Q, Li H, Kong Y, Li G, Wan Q, Zha Y, Hu Y, Xu G, Shi Y, Zhou Y, Su G, Tang Y, Gong M, Fan HF, Liu B. Clinical predictive factors and prediction models for end-stage renal disease in Chinese patients with type 2 diabetes mellitus. Clin Transl Med. 2023 Jul;13(7):e1323. 
4、Cai F, Zhou C, Jiao N, Liang X, Ye Z, Chen W, Yang Q, Peng H, Tang Y, Niu C, Zhao G, Wang Z, Zhang G, Yu X. Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy. Microbiol Spectr. 2023 Jun 15;11(3):e0520222.
5、Wu C, Zhang Y, Nie S, et al. Predicting in-hospital outcomes of patients with acute kidney injury. Nat Commun. 2023;14(1):3739.
6、Liangying Gan,Xiaoxi Lyu,Xiangdong Yang,Zhanzheng Zhao,Ying Tang et al.Application of Angiotensin Receptor–Neprilysin Inhibitor in Chronic Kidney Disease Patients:Chinese Expert Consensus.2022 July Front. Med. 9:877237.(IF: 5.058)
7、Junzhe Chen, Wenbiao Wang, Ying Tang, Xiao-ru Huang, Xueqing Yu, Hui-Yao Lan1,Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int J Biol Sci. 2021 Apr 10;17(6):1497-1506.(IF: 10.750)
8、Liao W, Liang P, Liu B, Xu Z, Zhang L, Feng M, Ying Tang, Xu A. MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1. Front Physiol. 2020;11:1093(IF: 4.755)
9、Min Feng, Jun Lv, Sha Fu, Bo Liu, Ying Tang, Xia Wan, Peifen Liang, YuchunZeng, Jingao Li, YanyingLu,Xiaomei Li, AnpingXu.Clinical features and mortality in Chinese withlupus nephritis and neuropsychiatric lupus:A 124-patient study. J Res Med Sci. 2014 May;19(5):414-9(IF 1.985 )
10、Liang P, Ying Tang, Fu S, Lv J, Liu B, Feng M, Li J, Lai D, Wan X, XuA.Basophilcount, a marker for disease activity in systemic lupus erythematosus. Clinical Rheumatology. 2015 May;34(5):891-6.( IF 3.65)
11、Haowen Zhong , Ya Liu , Zhenjian Xu , Peifeng Liang , Hui Yang , Xiao Zhang , Jun Zhao , Junzhen Chen , Sha Fu , Ying Tang , Jun Lv , Julie Wang , Nancy Olsen , Anping Xu, Song Guo Zheng. TGF-β-Induced CD8 + CD103 + Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells. Front Immunol. 2018 Jan 30;9:35. (IF 8.786 )
12、曾红惠,汤颖,陈俊哲,余文娟,黄秋燕,许燕纯,徐安平.腺苷酸活化蛋白激酶对缺氧肾小管上皮细胞线粒体片段化的影响.岭南急诊医学杂志,2019年4月,24(02):110-113.
 
三、著作:
第四版”肾脏病学”(人民卫生出版社)(第八章:肾脏损伤与修复 汤颖 蓝辉耀)